Endpoints in sarcoidosis: More like IPF or asthma?
Sarcoidosis remains an enigmatic disease. Its cause is unknown, the indications for treatment are often unclear, and its natural history is variable. An additional important enigmatic issue that has hampered clinical sarcoidosis research is the failure to develop reliable and universally accepted clinical endpoints.
Source: Respiratory Medicine - Category: Respiratory Medicine Authors: Marc A. Judson Tags: Editorial Source Type: research